2 cheap FTSE stocks with P/E ratios below 7!

These cheap FTSE stocks both offer exceptional value, based on current earnings forecasts. But as a long-term investor, should I consider buying them today?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Trader on video call from his home office

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Looking at a company’s price-to-earnings (P/E) ratio is a tool I use when looking for cheap FTSE stocks to buy.

Both of the following FTSE 100 shares trade on P/E ratios of below 7 times. Are they brilliant bargains or just investor traps?

Barclays

Price: 169p per share
P/E ratio: 6.5 times

Investing in Britain’s banks such as Barclays (LSE: BARC) is highly risky as the UK economy toils. GDP forecasts are being downgraded thick and fast with the British Chambers of Commerce (BCC) the latest to sound the alarm.

On Thursday, the business group trimmed its 2022 growth forecasts to 3.6%, from 3.5% previously. It also said it expects inflation to soar to 10% in the fourth quarter. It follows forecast cuts by the Organisation for Economic Co-operation and Development (OECD) midweek and warnings of zero growth in 2023.

In this climate, Barclays investors need to consider the prospect of soaring loan impairments and a slump in revenues.

On the plus side, a backdrop of rising inflation means that the Bank of England should keep hiking interest rates. This will boost profits Barclays makes on lending by widening the rates it offers to borrowers and savers. Indeed, the BCC predicts that benchmark rates will rise to 2% by the end of 2022, and 3% by the close of next year.

Still, it’s my opinion that the odds are stacked against Barclays in the near term. And the long-term outlook is quite spooky too as competition ramps up in the UK banking sector. I’m happy to avoid it right now.

Glencore

Price: 539p per share
P/E ratio: 5 times

Commodities business Glencore (LSE: GLEN) could experience significant bumpiness over the next 12-18 months. But I’d still buy it because its outlook for the rest of the decade looks quite thrilling.

Like Barclays, Glencore is a cyclical business that is highly sensitive to broader economic conditions. This FTSE 100 firm both produces and deals in raw materials all over the globe. The impact of soaring inflation on eonomic growth — and by extension on commodities demand — threatens to be severe.

This isn’t the only threat to Glencore in the near term either. Fresh Covid-19 lockdowns in Shanghai announced today illustrate the tough fight that commodities glutton China is having to contain a new wave of the pandemic.

All that being said, I’d buy Glencore in anticipation of a new ‘commodities supercycle’ over the next decade. The business can expect demand for its copper, cobalt, lead and zinc to soar as electric vehicle sales accelerate.

Consumption of its ferroalloys and iron ore, meanwhile, looks set to balloon as infrastructure spending picks up across the globe (and particularly so in emerging markets). Glencore’s vast operations put it (and its shareholders) in the box seat to exploit these trends.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Barclays. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »